|
SCRN3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.207960E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.410100E-04 |
| Normal-vs-Stage2 |
9.749900E-02 |
| Normal-vs-Stage3 |
9.440000E-02 |
| Normal-vs-Stage4 |
1.814410E-02 |
| Stage1-vs-Stage2 |
7.252600E-01 |
| Stage1-vs-Stage3 |
8.954400E-01 |
| Stage1-vs-Stage4 |
9.920600E-01 |
| Stage2-vs-Stage3 |
8.688200E-01 |
| Stage2-vs-Stage4 |
7.994400E-01 |
| Stage3-vs-Stage4 |
9.329200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.814680E-04 |
| Normal-vs-AfricanAmerican |
8.397000E-03 |
| Normal-vs-Asian |
6.320100E-02 |
| Caucasian-vs-AfricanAmerican |
8.274000E-01 |
| Caucasian-vs-Asian |
9.832600E-01 |
| AfricanAmerican-vs-Asian |
9.549200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.66720000044963E-07 |
| Normal-vs-Female |
7.007800E-01 |
| Male-vs-Female |
1.043150E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.262500E-02 |
| Normal-vs-Extreme_Weight |
3.23620000020064E-07 |
| Normal-vs-Obese |
1.151860E-02 |
| Normal-vs-Extreme_Obese |
4.581800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.231800E-01 |
| Normal_Weight-vs-Obese |
8.111600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.524000E-01 |
| Extreme_Weight-vs-Obese |
4.655900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.265420E-01 |
| Obese-vs-Extreme_Obese |
6.847600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.565160E-01 |
| Normal-vs-Age(41-60Yrs) |
6.244100E-03 |
| Normal-vs-Age(61-80Yrs) |
6.35679999999583E-05 |
| Normal-vs-Age(81-100Yrs) |
5.745900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.022000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.567580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.798000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.166360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.413800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.551600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.036480E-04 |
| Normal-VS-Type2 PRCC |
1.599550E-02 |
| Normal-VS-KIRP CIMP |
1.155240E-01 |
| Normal-VS-Unclassified PRCC |
2.626600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.380200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.951800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.650170E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.374000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.186800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.189000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.354800E-04 |
| Normal-vs-N1 |
2.509600E-01 |
| Normal-vs-N2 |
2.894500E-02 |
| N0-vs-N1 |
4.256800E-01 |
| N0-vs-N2 |
9.000600E-01 |
| N1-vs-N2 |
6.678000E-01 |
|
|
